Free Trial
OTCMKTS:USAQ

QHSLab Q4 2024 Earnings Results & Report

QHSLab logo
$0.27 -0.05 (-16.20%)
As of 10:00 AM Eastern

QHSLab reported Q4 2024 earnings on March 28, 2025. The company reported EPS of -$0.03, while revenue was $630 thousand.

Earnings Announcement Details

Quarter
Q4 2024
Report Date
Time
After Market Closes

QHSLab EPS Results

Actual EPS
-$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

QHSLab Revenue Results

Actual Revenue
$630 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

QHSLab's next earnings date is estimated for Tuesday, November 17, 2026, based on past reporting schedules.

Conference Call Resources

QHSLab Q4 2024 Earnings FAQ

QHSLab (OTCMKTS:USAQ) reported earnings of -$0.03 per share for Q4 2024. The report was announced on Friday, March 28, 2025.

QHSLab reported revenue of $630 thousand for Q4 2024.

QHSLab's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for QHSLab on the company's earnings history page.

QHSLab Earnings Headlines

QHSLab (OTCMKTS:USAQ) Stock Jumps 26.7% - Time to Buy?
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
QHSLab Inc.
See More QHSLab Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like QHSLab? Sign up for Earnings360's daily newsletter to receive timely earnings updates on QHSLab and other key companies, straight to your email.

About QHSLab

QHSLab (OTCMKTS:USAQ) is a healthcare technology and diagnostic services company focused on supporting the identification and management of chronic health conditions. The company combines laboratory testing with clinical decision-support tools intended to help healthcare providers make more informed treatment decisions.

Its offerings include diagnostic testing services and related digital or analytical solutions designed for use by medical professionals. These tools are intended to provide clinical information that can assist with patient evaluation, monitoring and ongoing care.

QHSLab serves the healthcare market through provider-focused products and services. Publicly available information about the company’s operating history, geographic reach and leadership is limited.

View QHSLab Profile